Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

KPTIKPTI
6 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in KARYOPHARM THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 1.4M shares of KPTI (KARYOPHARM THERAPEUTICS INC), worth $13.9M as of 2026-Q2. The position was increased (+50.4% shares). KPTI represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$13.9M

Current Shares

1.4M

Total Value Change

+$13.6M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+50.4%
$13.9M0.0%$9.77
39
2026-Q1
New
947,579
-
$5.3M0.0%$9.13
37
2025-Q4
Exited
0
-100.0%
$00.0%$7.31
0
2025-Q3
Decreased
24,885
-77.3%
$162,7480.0%$6.35
0
2025-Q2
Increased
109,404
+28.1%
$471,5310.0%$4.39
30
2025-Q1
New
85,410
-
$319,4330.0%$4.16
33

Other major holders of KPTI: RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used